Celldex Therapeutics Stock Forecast
Stronger technical forecast for Celldex Therapeutics stock price after Thursday trading.
(Updated on May 02, 2024)
The Celldex Therapeutics stock price gained 3.84% on the last trading day (Thursday, 2nd May 2024), rising from $39.35 to $40.86. It has now gained 5 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 5.68% from a day low at $38.75 to a day high of $40.95. The price has risen in 6 of the last 10 days and is up by 6.05% over the past 2 weeks. Volume fell on the last day by -310 thousand shares and in total, 551 thousand shares were bought and sold for approximately $22.51 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -5.52% during the next 3 months and, with a 90% probability hold a price between $34.03 and $47.08 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
CLDX Signals & Forecast
Mostly positive signals in the chart today. The Celldex Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $37.74 and $39.83. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, April 25, 2024, and so far it has risen 12.69%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.
Support, Risk & Stop-loss for Celldex Therapeutics stock
On the downside, the stock finds support just below today's level from accumulated volume at $38.25 and $37.75. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Celldex Therapeutics finds support just below today's level at $38.25. If this is broken, then the next support from accumulated volume will be at $37.75 and $36.26.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $2.20 between high and low, or 5.68%. For the last week, the stock has had daily average volatility of 5.10%.
Our recommended stop-loss: $39.49 (-3.36%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 5 days ago.)
Trading Expectations (CLDX) For The Upcoming Trading Day Of Friday 3rd
For the upcoming trading day on Friday, 3rd we expect Celldex Therapeutics to open at $40.19, and during the day (based on 14 day Average True Range), to move between $39.03 and $42.69, which gives a possible trading interval of +/-$1.83 (+/-4.49%) up or down from last closing price. If Celldex Therapeutics takes out the full calculated possible swing range there will be an estimated 8.98% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $38.25 (6.39%) than the resistance at $48.23 (18.04%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Celldex Therapeutics stock A Buy?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.
Current score: 3.033 Buy Candidate Upgraded
Predicted Opening Price for Celldex Therapeutics of Friday, May 3, 2024
| Fair opening price May 3, 2024 | Current price |
|---|---|
| $40.19 ( 1.65%) | $40.86 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for CLDX
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 42.39 | 3.74 % | |
| R2 | 41.55 | 1.68 % | ||
| R1 | 41.03 | 0.409 % | ||
| Current price: | 40.86 | |||
| Support | S1 | 39.35 | -3.70 % | |
| S2 | 38.83 | -4.98 % | ||
| S3 | 37.99 | -7.03 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 51.04 | 24.91 % | |
| R2 | 50.01 | 22.39 % | ||
| R1 | 48.23 | 18.04 % | ||
| Current price | 40.86 | |||
| Support | S1 | 38.25 | -6.39% | |
| S2 | 37.75 | -7.61% | ||
| S3 | 36.26 | -11.26% |
FAQ
Click here for our free guide on how to buy Celldex Therapeutics Stock.
